Tokyo, Feb. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060576) titled 'A prospective study to assess the therapeutic effect of 177Lu-PSMA in patients with metastatic castration-resistant prostate cancer' on Feb. 4.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Gunma University
Condition:
Condition - metastatic castration resistant prostate cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To analyze the efficacy of SPECT/CT images taken after LuPSMA treatment to assess treatment efficacy....